Glenmark Life Sciences (BOM:543322) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Glenmark Life Sciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Glenmark Life Sciences's Free Cash Flow for the three months ended in Mar. 2024 was ₹0 Mil. Glenmark Life Sciences's Revenue for the three months ended in Mar. 2024 was ₹5,366 Mil. Therefore, Glenmark Life Sciences's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Glenmark Life Sciences's current FCF Yield % is 2.68%.

The historical rank and industry rank for Glenmark Life Sciences's FCF Margin % or its related term are showing as below:

BOM:543322' s FCF Margin % Range Over the Past 10 Years
Min: 0.08 Med: 11.05 Max: 22.3
Current: 12.46

During the past 6 years, the highest FCF Margin % of Glenmark Life Sciences was 22.30%. The lowest was 0.08%. And the median was 11.05%.

BOM:543322's FCF Margin % is ranked better than
80.55% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 0.49 vs BOM:543322: 12.46

Glenmark Life Sciences FCF Margin % Historical Data

The historical data trend for Glenmark Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Life Sciences FCF Margin % Chart

Glenmark Life Sciences Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

9.63

17.20

22.30

6.63

12.46

Glenmark Life Sciences Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Glenmark Life Sciences's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Glenmark Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Glenmark Life Sciences's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Glenmark Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Glenmark Life Sciences's FCF Margin % falls into.

Glenmark Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Glenmark Life Sciences's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	2845.46	/	22832.14
	=	12.46 %

Glenmark Life Sciences's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	5365.97
	=	0.00 %

Glenmark Life Sciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of Glenmark Life Sciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Glenmark Life Sciences (BOM:543322) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Life Sciences Ltd (BOM:543322) » Definitions » FCF Margin %

Traded in Other Exchanges

GLS:India

Address

470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400099

Website

https://www.glenmarklifesciences.com

Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Glenmark Life Sciences (BOM:543322) Headlines

No Headlines